Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Lidocaine Infusion in Stomach Cancer Surgery
NCT04868747Withdrawn
- Sponsor
- The Catholic University of Korea
- Start
- Apr 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Lidocaine Hydrochloride Injection, without epinephrine in gastric cancer (GC) (2 arms), sponsored by The Catholic University of Korea. Primary endpoint: Serum concentration of NET (neutrophil extracellular trapping)-related biomarker. Planned start Apr 2021; status: withdrawn.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04868747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04868747.